GYROSCOPE

Owners

Goods & Services

Medical and veterinary apparatus and instruments for ocular surgery; ophthalmic apparatus and instruments, namely, surgical apparatus for use in ophthalmic surgery; apparatus and instruments for treating the eye, namely, cannulas and needles for obtaining sub-retinal access; apparatus and instruments for dispensing or delivering preparations into the eye or structures thereof, namely, cannulas and needles for the delivery and administration of gene therapy preparations, to the eye for the treatment of eye conditions; apparatus and instruments for performing eye surgery, namely, cannulas and needles; parts and fittings for the aforesaid goods

Medical and veterinary preparations for therapeutic purposes, namely, for the prevention and treatment of age-related macular degeneration, geographic atrophy and other ophthalmological diseases and disorders; pharmaceutical preparations for gene therapy, namely, nucleic acids, viral and non-viral vectors; biologic preparations for medical purposes, namely, biological preparations for the prevention and treatment of age-related macular degeneration, geographic atrophy and other eye diseases; biologic preparations for use in treatment of genetically based diseases and disorders, namely, age-related macular degeneration, geographic atrophy and other ophthalmological diseases and disorders; biologic preparations for use in the treatment of ophthalmological diseases and disorders; biologic preparations for use in the treatment of blinding diseases and disorders; biologic preparations for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for use in treatment of genetically based diseases and disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for medical purposes; gene therapy preparations in the nature of nucleic acids and viral vectors for use in the treatment of ophthalmological diseases and disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for use in the treatment of blinding diseases and disorders; gene therapy preparations in the nature of nucleic acid and viral vectors for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders